American Academy of Neurology: Costs Still on the Rise for Drugs for Neurological Diseases
October 31, 2024
October 31, 2024
MINNEAPOLIS, Minnesota, Oct. 31 (TNSres) -- The American Academy of Neurology issued the following news release:
The amount of money people pay out-of-pocket for branded drugs to treat neurological diseases like multiple sclerosis (MS), Alzheimer's, and Parkinson's disease continues to rise, especially for MS drugs, according to a study published in the October 30, 2024, online issue of Neurology(R), the medical journal of the American Academy of Neurology. The study found that aver . . .
The amount of money people pay out-of-pocket for branded drugs to treat neurological diseases like multiple sclerosis (MS), Alzheimer's, and Parkinson's disease continues to rise, especially for MS drugs, according to a study published in the October 30, 2024, online issue of Neurology(R), the medical journal of the American Academy of Neurology. The study found that aver . . .